Brief: Fibrobiologics, Inc. Announces Issuance Of U.S. Patent Covering Fibroblast Cell Therapy For The Treatment Of Osteoporosis
02/03/2026 13:41
March 2 (Reuters) - Fibrobiologics Inc FBLG.O: FIBROBIOLOGICS, INC. ANNOUNCES ISSUANCE OF U.S. PATENT COVERING FIBROBLAST CELL THERAPY FOR THE TREATMENT OF OSTEOPOROSIS Source text: ID:nGNX7SwmFG Further company coverage: FBLG.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fibrobiologics
See all newsBrief: Fibrobiologics Files Patent Application For Technology Designed To Produce Glp-1 And Other Therapeutic Peptides Inside The Body
Brief: Fibrobiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair In Preclinical Study Of Degenerative Joints
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
Brief: Fibrobiologics Granted US Patent Covering The Use Of Fibroblasts